Stryker

CIK 0000310764 · SYK NYSE

SIC
3841 · Surgical and Medical Instruments
Type
Operating
Status
Public
Filer
Large accelerated filer
Incorporated
Michigan
FY End
Dec 31

Business Summary

Stryker Corporation is a global leader in medical technologies, offering innovative products and services across MedSurg, Neurotechnology, and Orthopaedics that impact more than 150 million patients annually. Founded in 1941 and incorporated in Michigan in 1946, the company reported total net sales of $25.1 billion in 2025, up from $22.6 billion in 2024. Stryker sells products in approximately 61 countries through company-owned subsidiaries and third-party distributors, primarily marketing directly to doctors, hospitals, and healthcare facilities.

Products & Services

  • Instruments ($3.2B, 2025): Surgical equipment, navigation systems, patient/caregiver safety technologies (Steri-Shield 8, Guard Medical wound therapy)
  • Endoscopy ($3.8B): 4K 1788 Camera platform, Connected OR IP BRAVoE integration, endoscopic/communications systems
  • Medical ($4.2B): LIFEPAK 35 monitor/defibrillator, Vocera Sync Badge clinical communication, AI-assisted virtual care, ICU disposables, emergency medical equipment
  • Vascular ($2.0B): Minimally invasive stroke treatment (Broadway System), venous thromboembolism (Inari Medical acquisition), flow diverting stents (Surpass...
Get a free account in seconds to read the full business overview. Create free account

AI-generated summary of Item 1 (Business) from the 10-K filed Feb 11, 2026 — View filing on SEC.gov. May contain errors — refer to the filing for authoritative information.

Across SEC filings

Institutional holders · 13F

Q2 2026
2,271 managers reported a position for Q2 2026 -50 vs Q1 2026
Largest Q2 2026 Form 13F holders of Stryker by reported value
Largest holders Reported value
BlackRock Inc $8.6B
VANGUARD CAPITAL MANAGEMENT LLC $7.1B
JPMorgan Chase & Co $5.7B
STATE STREET CORPORATION $4.9B
GREENLEAF TRUST $4.8B

Annual results · 10-K

Fiscal 2025
Revenue
$25.1B
Net income
$3.2B

As reported in the fiscal 2025 annual report.

Funds & ETFs · N-PORT

977 funds
Largest fund holders reported on Form N-PORT
Fund Value % of fund
VANGUARD TOTAL STOCK MARKET INDEX FUND VTI $3.4B 0.15%
VANGUARD 500 INDEX FUND VOO $2.8B 0.17%
iShares Core S&P 500 ETF IVV $1.5B 0.17%
Fidelity 500 Index Fund $1.5B 0.17%
State Street(R) Health Care Select Sector SPDR(R) ETF XLV $767.4M 1.89%
VANGUARD DIVIDEND GROWTH FUND $728.2M 2.05%
VANGUARD WELLINGTON FUND $682.1M 0.56%
VANGUARD DIVIDEND APPRECIATION INDEX FUND VIG $635.8M 0.49%
VANGUARD GROWTH INDEX FUND VUG $634.5M 0.17%
VANGUARD INSTITUTIONAL INDEX FUND $589.7M 0.17%

977 funds reported holding $30.9B in total on their latest public Form N-PORT reports, the most recent dated September 2026. Security record

Insider trades · Form 4

-$580M net open-market insider transactions, last 12 months 1 filing with purchases ($26.7K), 11 filings with sales ($580M)

Latest filings

5%+ holders · 13D/G

3 filers
Schedule 13D and 13G filers reporting a stake of 5% or more
Filer % of class Filed
VANGUARD CAPITAL MANAGEMENT LLC 13G 6.7% 2026-04-30
STRYKER RONDA E 13D 4.0% 2026-04-14
GREENLEAF TRUST 13G 4.4% 2026-02-11

Latest Schedule 13D or 13G from each filer; stakes a filer has reported closed are left out.

Federal lobbying · LD-2

$1.3M reported spend, four quarters through Q3 2026

Securities

Securities issued by this company
CUSIP Security Type
863667101 SYK STRYKER CORP Common stock

Latest SEC filings

All filings →
Latest SEC filings by Stryker
Form Description Filed
4 Insider Transaction · Ronda E Stryker 2026-11-09
8-K Current Report 2026-11-09
144 144 2026-11-05
S-3ASR S-3ASR 2026-11-04
IRANNOTICE IRANNOTICE 2026-10-30
10-Q Quarterly Report 2026-10-30
8-K Current Report 2026-10-29
8-K Current Report 2026-10-06
4 Insider Transaction · Preston Wendell Wells 2026-09-28
4 Insider Transaction · Preston Wendell Wells 2026-09-24
Loading ownership data...
Loading insider trading data...
Loading financials...

Quality is a Plus feature

See why the score is what it is — the score history and the full test-by-test breakdown behind the composite.

Valuation is a Premium feature

What this company is worth versus its price — fair value at today's bond rate, margin of safety, and the Graham Number against the institutional consensus price.

Loading SEC filings...
Loading sponsor profile...